Dataset Information


Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen.

ABSTRACT: This study aims to identify effective gene networks and prognostic biomarkers associated with estrogen receptor positive (ER+) breast cancer using human mRNA studies. Weighted gene coexpression network analysis was performed with a complex ER+ breast cancer transcriptome to investigate the function of networks and key genes in the prognosis of breast cancer. We found a significant correlation of an expression module with distant metastasis-free survival (HR = 2.25; 95% CI .21.03-4.88 in discovery set; HR = 1.78; 95% CI = 1.07-2.93 in validation set). This module contained genes enriched in the biological process of the M phase. From this module, we further identified and validated 5 hub genes (CDK1, DLGAP5, MELK, NUSAP1, and RRM2), the expression levels of which were strongly associated with poor survival. Highly expressed MELK indicated poor survival in luminal A and luminal B breast cancer molecular subtypes. This gene was also found to be associated with tamoxifen resistance. Results indicated that a network-based approach may facilitate the discovery of biomarkers for the prognosis of ER+ breast cancer and may also be used as a basis for establishing personalized therapies. Nevertheless, before the application of this approach in clinical settings, in vivo and in vitro experiments and multi-center randomized controlled clinical trials are still needed.


PROVIDER: S-EPMC4622923 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4269343 | BioStudies
2014-01-01 | S-EPMC4059381 | BioStudies
2019-01-01 | S-EPMC6857166 | BioStudies
1000-01-01 | S-EPMC5694002 | BioStudies
1000-01-01 | S-EPMC5667424 | BioStudies
2015-01-01 | S-EPMC4618922 | BioStudies
2020-01-01 | S-EPMC6941974 | BioStudies
1000-01-01 | S-EPMC6037086 | BioStudies
2014-01-01 | S-EPMC3879319 | BioStudies
2013-01-01 | S-EPMC3371315 | BioStudies